Platelet transfusion study for very preterm babies
Part of Blood & lymphatic, Genetic & congenital, Heart & circulation clinical trials.
This study looks at the best way to decide when to give platelet transfusions to very premature babies. It aims to help prevent bleeding while avoiding unnecessary transfusions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was born between 23 and 27 weeks of pregnancy.
- Your baby is less than 2 days old (48 hours).
- Doctors are not planning to stop active treatment and focus only on comfort care.
- Your baby does not have a known bleeding disorder or a condition that destroys platelets.
- Your baby has not already received a platelet transfusion.
- Your baby received a vitamin K shot after birth.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether giving smaller volumes of platelet transfusions to premature babies with very low platelet counts is as effective as the standard larger volume. It aims to find a safer way to prevent bleeding while reducing risks like fluid overload.
This trial tests how a platelet transfusion affects blood vessel function in intensive care patients with low platelet counts (thrombocytopenia). It may help doctors understand if transfusions help the tiny blood vessels work better.
This study tests a machine called ROTEM Sigma that measures how well your blood clots, specifically in pregnant women who have or may have low platelet counts (cells that help blood clot). The goal is to help doctors better predict bleeding problems during or after delivery.
This study looks at platelet transfusions—how they’re used and whether platelets function well—for people with blood cancers who have low platelet counts. It may help improve transfusion care for people who need platelet support.
This trial looks at how to estimate bleeding risk in newborns who are very premature and have a low platelet count. The goal is to guide safer care by better identifying which babies may be at higher risk of bleeding.
This study looks at how very low platelet levels (and platelet transfusions, if needed) affect bleeding and inflammation in newborns. It may help doctors better understand which newborns are at higher risk and how to manage low platelets.
Hear when a new Thrombocytopenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.